Combination of the gene expression from Oncomine and survival from PrognoScan revealed the oncogenic role of ACSL4 in colorectal cancer and the tumor suppressor role of ACSL4 in breast, brain, and lung cancer. The gene discussed is ACSL4; the disease is neoplasm.